Trinity Street Asset Management’s Charles River Laboratories CRL Stock Holding History

Trinity Street Asset Management’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-198,226	Closed	-$44.9M	–	24
2020 Q3	$44.9M	Sell	198,226 -48,649	-20%	-$10.1M	5.46%	4
2020 Q2	$43M	Buy	246,875 +7,902	+3%	+$1.26M	6.37%	4
2020 Q1	$30.2M	Buy	238,973 +46,104	+24%	+$6.91M	5.17%	8
2019 Q4	$29.5M	Buy	192,869 +7,094	+4%	+$982K	4%	15
2019 Q3	$24.6M	Buy	185,775 +41,400	+29%	+$5.55M	3.82%	16
2019 Q2	$20.5M	Buy	+144,375	New	+$19.6M	3.98%	14

Other funds holding CRL

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $26.8B AUM 3.69% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $144B AUM 22.91% 1-Year Est. Return

Trinity Street Asset Management's CRL Position: Q4 2020 in Review

Trinity Street Asset Management sold out of Charles River Laboratories (CRL) in Q4 2020, closing a stake of 198,226 shares — an estimated $44.9M sold.

Trinity Street Asset Management first reported a position in CRL in Q2 2019 and held it in 6 quarters. The position peaked at $44.9M in Q3 2020. 539 funds tracked by Wall St. Rank hold CRL as of Q4 2020.

Trinity Street Asset Management reported no remaining Charles River Laboratories position as of Q4 2020 after selling out during the quarter.
Trinity Street Asset Management sold 198,226 Charles River Laboratories shares in Q4 2020, an estimated $44.9M.
Trinity Street Asset Management first reported a position in Charles River Laboratories in Q2 2019 and held it in 6 quarters.
Trinity Street Asset Management's Charles River Laboratories position peaked at $44.9M in Q3 2020.
539 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2020.

Based on Trinity Street Asset Management's 13F filing for Q4 2020, filed 22 Jan 2021.